Common Stock, $0.01 par value per share

Payoneer Global Inc.

195 Broadway, 27th floor, New York, NY, 10007

Item 2(a) of the Schedule 13D is amended and supplemented as follows: This Schedule 13D is being filed by (1) Technology Crossover Management VIII, Ltd., a Cayman Islands exempted company ("Management VIII"), (2) Technology Crossover Management VIII, L.P., a Cayman Islands exempted limited partnership ("TCM VIII"), (3) TCV VIII, L.P., a Cayman Islands exempted limited partnership ("TCV VIII"), (4) TCV VIII (A), L.P., a Cayman Islands exempted limited partnership ("TCV VIII (A)"), (5) TCV VIII (B), L.P., a Cayman Islands exempted limited partnership ("TCV VIII (B)"), (6) TCV Member Fund, L.P., a Cayman Islands exempted limited partnership ("Member Fund"), (7) TCV VIII Management, L.L.C., a Delaware limited liability company ("TCV VIII Management"), and (8) Christopher P. Marshall. The foregoing entities and individual are collectively referred to herein as the "Reporting Persons." The agreement among the Reporting Persons relating to the joint filing of this Schedule 13D is attached as Exhibit 99.1. TCV VIII, TCV VIII (A), TCV VIII (B) and Member Fund (collectively, the "TCV Entities") are each principally engaged in the business of investing in securities of privately and publicly held companies. TCV VIII Management is principally engaged in the business of managing funds that invest in securities of privately and publicly held companies. Management VIII is the sole general partner of TCM VIII, which in turn is the sole general partner of TCV VIII, TCV VIII (A), TCV VIII (B) (the "TCV VIII Funds"). Management VIII is a general partner of Member Fund. Mr. Marshall is a Class A Director of Management VIII, a limited partner of TCM VIII and Member Fund and a member of TCV VIII Management. The address of the principal business and office of each of the Reporting Persons is c/o TCV, 250 Middlefield Road, Menlo Park, California 94025.

Item 2(b) of the Schedule 13D is amended as follows: The information set forth in Item 2(a) of this Schedule 13D is hereby incorporated herein by reference.

Item 2(c) of the Schedule 13D is amended as follows: The information set forth in Item 2(a) of this Schedule 13D is hereby incorporated herein by reference.

Item 2(f) of the Schedule 13D is amended as follows: The information set forth in Item 2(a) of this Schedule 13D is hereby incorporated herein by reference.

Item 5(a) of the Schedule 13D is amended as follows: The percentage of Common Stock beneficially owned is based on 334,778,664 shares of Common Stock outstanding as of April 30, 2026, as reported in the Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed by the Company with the Securities and Exchange Commission on May 7, 2026. Excluded from beneficial ownership is the contingent right to earn-out shares and shares issuable upon RSUs that do not vest within 60 days of the date hereof.

Item 5(b) of the Schedule 13D is amended as follows: The aggregate number of shares of Common Stock beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition are set forth on rows 7 through 11 and row 13 of the cover pages of this Amendment No. 2 and are incorporated herein by reference. Each of the TCV Entities and TCV VIII Management has the sole power to dispose or direct the disposition of the shares of Common Stock that it holds directly and has the sole power to vote or direct the vote of such shares. Management VIII, as the ultimate general partner of the TCV Entities, may be deemed to have the sole power to dispose or direct the disposition of the shares held by the TCV Entities and have the sole power to direct the vote of such shares of Common Stock. TCM VIII, as the direct general partner of the TCV VIII Funds, may also be deemed to have sole power to dispose or direct the disposition of the shares of Common Stock held by the TCV VIII Funds and have the sole power to direct the vote of such shares of Common Stock. Each of Management VIII and TCM VIII disclaims beneficial ownership of the shares of Common Stock owned by the TCV Entities, except to the extent of their respective pecuniary interest therein. Christopher P. Marshall is a Class A Director of Management VIII, a limited partner of TCM VIII and Member Fund and a member of TCV VIII Management. Mr. Marshall has sole dispositive power over the shares issued upon settlement of the RSUs he holds directly. However, TCV VIII Management has a right to 100% of the pecuniary interest in such RSUs and the shares to be received upon the settlement of such RSUs. Mr. Marshall disclaims beneficial ownership of the shares of Common Stock held by the TCV Entities and TCV VIII Management and the shares of Common Stock held in his name for the benefit of TCV VIII Management, except to the extent of his pecuniary interest therein. The Reporting Persons may be deemed to be acting as a group in relation to their respective holdings in the Company but do not affirm the existence of any such group. Except as set forth in this Item 5(b), each of the Reporting Persons disclaims beneficial ownership of any Common Stock owned beneficially or of record by any other Reporting Person.

Item 5(c) of the Schedule 13D is supplemented as follows: No transactions with respect to the shares of Common Stock were effected during the past 60 days by any of the Reporting Persons.

Except as set forth herein, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the Common Stock beneficially owned by the Reporting Persons.

Not applicable.